|
|
 |
|
Pharmaceutical Solutions
Dear Potential Partner,
November 2000 marked a major shift in the delivery of injectable medications. The enactment of The Needlestick Safety and Prevention Act caused healthcare employers to get serious about protecting workers from the horror of needlesticks. OSHA inspections and citations for not appropriately protecting health care employees are now a reality and similar legislative measures are expected to be implemented soon throughout Europe.
 The mission of Safety Syringes, Inc. is to bring you the very best drug delivery and safety solutions for unit-dose, prefilled pharmaceutical presentations. To that end, our UltraSafe Passive® Delivery System, launched with Pfizer's Fragmin in August 2002, meets or exceeds all design criteria recommended by the FDA and NIOSH. Time and again, market research has demonstrated that the UltraSafe Passive® Delivery System is overwhelmingly preferred, not only to current methods of delivery, but to competitive products as well.
When integrated with your pharmaceutical presentations, the UltraSafe Passive® Delivery System will help differentiate your products and provide greater competitive advantage. Available since 1999, our clinically proven products are now being used by leading pharmaceutical companies including Abbott, AstraZenica International, Amgen, Ortho Clinical Diagnostics, Pfizer and Talecris Biotherapeutics (formerly Bayer.) Soon, others will also be using our products for new drug presentations being readied for introduction into the United States and Europe.
UltraSafe products and services can be easily integrated into your manufacturing and packaging processes. Our technology is available for a full range of prefilled glass syringes from 0.5mL to 2.25mL and can be used with staked needles as well as luer slip and luer lock presentations. To make integration simple and seamless, we have partnered with leading automation providers as well as premier packaging vendors to ensure maximum flexibility and the fastest time to market.
With 17 U.S. and International patents and several patents pending, Safety Syringes, Inc. is working diligently on broadening our product offerings to provide even better and safer product solutions. As an example, we will soon make available a revolutionary system based on our preferred Passive Delivery System platform, which has the potential of preventing drug tampering or adulteration, an issue of increasingly global concern. We are also perfecting product offerings for the growing self-injection market as well as a safe and easy-to-use solution for reconstitution and delivery of lyophilized drugs.
When you partner with Safety Syringes, Inc. you will be rewarded with immediate access to the most advanced delivery systems and clinically proven technology available. No other company can match our products, our services, or the overwhelming user preference. That makes it a partnership you can depend on today and into the future.
Sincerely,
Christer Andreasson
Chairman and CEO
|
|
|
